Tumor-associated macrophages regulate gastric cancer cell invasion and metastasis through TGFβ2/NF-κB/Kindlin-2 axis.

Gastric cancer Kindlin-2 invasion and metastasis tumor-associated macrophage

Journal

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
ISSN: 1000-9604
Titre abrégé: Chin J Cancer Res
Pays: China
ID NLM: 9315242

Informations de publication

Date de publication:
Feb 2020
Historique:
entrez: 21 3 2020
pubmed: 21 3 2020
medline: 21 3 2020
Statut: ppublish

Résumé

Recent studies have shown that tumor-associated macrophages (TAMs) play an important role in cancer invasion and metastasis. Our previous studies have reported that TAMs promote the invasion and metastasis of gastric cancer (GC) cells through the Kindlin-2 pathway. However, the mechanism needs to be clarified. THP-1 monocytes were induced by PMA/interleukin (IL)-4/IL-13 to establish an efficient TAM model We found that Kindlin-2 expression was upregulated at both mRNA and protein levels in GC cells cocultured with TAMs, associated with higher invasion rate. Kindlin-2 knockdown reduced the invasion rate of GC cells under coculture condition. TGFβ2 secreted by TAMs regulated the expression of Kindlin-2 through the transcription factor NF-кB. TAMs thus participated in the progression of GC through the TGFβ2/NF-κB/Kindlin-2 axis. Kindlin-2 expression and TAM infiltration were significantly positively correlated with TNM stage, and patients with high Kindlin-2 expression had significantly poorer overall survival than patients with low Kindlin-2 expression. Furthermore, Kindlin-2 promoted the invasion of GC cells This study elucidates the mechanism of TAMs participating in GC cell invasion and metastasis through the TGFβ2/NF-κB/Kindlin-2 axis, providing a possibility for new treatment options and approaches.

Identifiants

pubmed: 32194307
doi: 10.21147/j.issn.1000-9604.2020.01.09
pii: cjcr-32-1-72
pmc: PMC7072013
doi:

Types de publication

Journal Article

Langues

eng

Pagination

72-88

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Chinese Journal of Cancer Research. All rights reserved.

Références

BMC Cancer. 2010 Aug 11;10:419
pubmed: 20699000
Crit Rev Oncol Hematol. 2009 Aug;71(2):127-64
pubmed: 19230702
PLoS One. 2013;8(1):e54302
pubmed: 23372702
Am J Surg. 2012 Feb;203(2):222-9
pubmed: 22056622
Cancer Treat Rev. 2014 Jul;40(6):692-700
pubmed: 24656602
J Clin Oncol. 2015 Sep 10;33(26):2863-9
pubmed: 26240224
Clin Exp Metastasis. 2004;21(2):129-38
pubmed: 15168730
Dermatology. 2014;229(4):369-78
pubmed: 25401296
Cardiovasc Toxicol. 2006;6(2):111-30
pubmed: 17303919
Int J Mol Sci. 2016 Mar 01;17(3):320
pubmed: 26938527
Cancer Lett. 2015 May 28;361(1):75-85
pubmed: 25724625
Surgery. 2014 Jan;155(1):74-84
pubmed: 24238122
J Investig Med. 2017 Aug;65(6):991-998
pubmed: 28442533
EMBO Rep. 2012 Aug;13(8):750-8
pubmed: 22699938
Genome Biol. 2007;8(5):215
pubmed: 17543136
J Mol Med (Berl). 2013 Apr;91(4):411-29
pubmed: 23515621
Oncogene. 2006 Oct 30;25(51):6680-4
pubmed: 17072321
Recent Prog Horm Res. 2003;58:95-130
pubmed: 12795416
Cold Spring Harb Perspect Biol. 2017 Dec 1;9(12):
pubmed: 28246180
J Cell Sci. 2000 Mar;113 ( Pt 5):869-76
pubmed: 10671376
Cell Immunol. 2017 Jun;316:1-10
pubmed: 28433198
Nat Immunol. 2014 May;15(5):423-30
pubmed: 24681566
J Am Soc Nephrol. 2013 Sep;24(9):1387-98
pubmed: 23723426
J Pathol. 2019 Nov;249(3):381-394
pubmed: 31292963
Science. 2001 Aug 24;293(5534):1495-9
pubmed: 11520989
J Biol Chem. 2004 Oct 15;279(42):43503-13
pubmed: 15292257
Blood. 2012 Mar 29;119(13):e110-9
pubmed: 22323479
Leukemia. 2017 Jan;31(1):100-106
pubmed: 27338259
Clin Oncol (R Coll Radiol). 2007 Mar;19(2):154-61
pubmed: 17355113
Cell. 2003 Apr 4;113(1):37-47
pubmed: 12679033
Med Oncol. 2015 Feb;32(2):352
pubmed: 25572805
Chin J Cancer Res. 2018 Jun;30(3):291-298
pubmed: 30046223
J Exp Clin Cancer Res. 2017 Sep 29;36(1):134
pubmed: 28969700
Cancer Res. 2011 Apr 1;71(7):2739-49
pubmed: 21310825
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
Onco Targets Ther. 2016 Jun 30;9:3975-83
pubmed: 27418840
Cytokine Growth Factor Rev. 2015 Aug;26(4):389-403
pubmed: 26119834
Genes Dev. 2008 May 15;22(10):1325-30
pubmed: 18483218
Cancer Lett. 2017 Apr 1;390:103-114
pubmed: 28093281
Oncogene. 2010 Aug 26;29(34):4766-78
pubmed: 20543863
Annu Rev Immunol. 2000;18:621-63
pubmed: 10837071
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
PLoS One. 2013 Nov 15;8(11):e80908
pubmed: 24260507
Br J Cancer. 2006 Aug 7;95(3):272-81
pubmed: 16832418
Annu Rev Biochem. 1998;67:753-91
pubmed: 9759503
Gut. 2019 Oct;68(10):1764-1773
pubmed: 30661053
Semin Cancer Biol. 2012 Aug;22(4):289-97
pubmed: 22349514
Cell. 2000 Oct 13;103(2):295-309
pubmed: 11057902

Auteurs

Zhu Wang (Z)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Yang Yang (Y)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Yancheng Cui (Y)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.
Department of Surgery, Helsinki University Central Hospital, and University of Helsinki, Helsinki 00290, Finland.

Chao Wang (C)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Zhiyong Lai (Z)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Yansen Li (Y)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Wei Zhang (W)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Harri Mustonen (H)

Department of Surgery, Helsinki University Central Hospital, and University of Helsinki, Helsinki 00290, Finland.

Pauli Puolakkainen (P)

Department of Surgery, Helsinki University Central Hospital, and University of Helsinki, Helsinki 00290, Finland.

Yingjiang Ye (Y)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Kewei Jiang (K)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Zhanlong Shen (Z)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Shan Wang (S)

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing 100044, China.
Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.

Classifications MeSH